Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Issuance Of Securities On Preferential Basis To Non Promoters

 The Board of Directors of the Company, at its meeting held today i.e. Tuesday, 06th July, 2021 have inter-alia, considered and approved following: i. Issuance of following securities on Preferential basis to Non Promoters: Subject to approval of the shareholders of the Company and such other regulatory/governmental approvals, the Board has approved to issue and allot on preferential basis, the following securities a. Issuance of upto 15,00,000, 11% Unsecured Compulsorily Convertible Debentures (CCDs) to Florintree Innovation LLP on a preferential basis b. Issuance of upto 7,50,000, warrants to Ms. Elizabeth Mathew on a preferential basis at a price of Rs. 122/- per warrant (convertible to equity) ii. The Board of Directors have also approved convening of an Extra Ordinary General Meeting on Saturday, July 31, 2021
06-07-2021
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Intimation for Proposal To Raise Funds By Issuance Of Securities I.E. Equity And /Or Unsecured Compulsorily Convertible Debentures And/ Or Warrants And / Or Other Securities Of The Company On A Preferential Basis

 GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/07/2021 ,inter alia, to consider and approve This is to inform you that pursuant to Regulation 29 (1) (d) and other applicable provision of SEBI Listing Regulations, a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 6th July, 2021 to inter-alia consider and approve following business: a. Proposal to raise funds by issuance of securities i.e. Equity and /or unsecured compulsorily convertible debentures and/ or warrants and / or other securities of the Company on a preferential basis subject to approval of members of the Company and in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, the Companies Act, 2013 and other applicable rules, regulations and guidelines. b. Proposal to seek shareholder's approval on aforesaid matter by calling an Extraordinary General Meeting. Please take the above on your records.
01-07-2021
Bigul

Genesys International Corporation Ltd - 506109 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 We are enclosing herewith the copy of Audited standalone and consolidated financial results of the Company for the quarter and financial year ended March 31, 2021as published in the newspaper - The Free Press Journal (English) and Navshakti (Marathi).
01-07-2021
Bigul

Genesys International Corporation Ltd - 506109 - Closure of Trading Window

 This is to inform you that as per the Company's Code of Conduct framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company shall remain closed for all Designated Persons and their immediate relatives from July 01, 2021 till the expiry of 48 hours after the declaration of financial results of the Company for the quarter ended June 30, 2021.
30-06-2021
Bigul

Genesys International Corporation Ltd - 506109 - Outcome Of Board Meeting Held On June 29, 2021

 In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today has inter alia considered and approved:- Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2021 along with Statement of Asset and Liabilities as at March 31, 2021. Copies of the following enclosed as Annexure A a. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2021. b. Auditors' Report along-with a Declaration in respect of Unmodified opinion on the Audited Financial Results. The meeting of Board commenced at 07:30 p.m. and concluded at 9:00 p.m.
29-06-2021
Bigul

Genesys International Corporation Ltd - 506109 - Results - Financial Results For The Quarter And Financial Year Ended March 31, 2021

 In compliance with the provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held today has inter alia considered and approved:- Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2021 along with Statement of Asset and Liabilities as at March 31, 2021. Copies of the following enclosed as Annexure A a. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2021. b. Auditors' Report along-with a Declaration in respect of Unmodified opinion on the Audited Financial Results. The meeting of Board commenced at 07:30 p.m. and concluded at 9:00 p.m.
29-06-2021
Bigul

Genesys International Corporation Ltd - 506109 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report for the Financial Year 2020-21 under Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking you.
28-06-2021
Bigul

Genesys International Corporation Ltd - 506109 - Board Meeting Intimation for Approval The Audited Financial Results For The Financial Year Ended March 31, 2021.

 GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31, 2021.
22-06-2021

Genesys announces free Rapid Response solution for Covid-19 support in India

 The solution helped more than 700 organisations maintain business continuity
02-06-2021
Bigul

GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Intimation Of The Grant Of Options Under Genesys ESOP Scheme, 2010

 We would like to inform you that the Compensation Committee of the Board of Directors of the Company at its meeting held today i.e. May 25, 2021 considered and approved re-grant of 21,800 Stock Options out of the lapsed Options to its eligible employees under the Company's ESOP Scheme- 2010. One Stock Option grant represents one equity share of Rs. 5/- each of the Company. The above Options were granted at an exercise price of Rs. 67.75 per equity share, which is at 29.39% discount to the closing price of Rs. 95.95 of the company's equity share on the National Stock Exchange of India on May 24, 2021.
25-05-2021
Next Page
Close

Let's Open Free Demat Account